Christine Baeder

Christine Baeder is the President of Apotex Corp and recently served as chair of the AAM board. Prior to joining Apotex, Christine spent over twenty years in senior roles with Organon Pharmaceuticals, Sandoz Inc., and most recently with Teva Pharmaceuticals as SVP and COO of the US Generics and Global Biosimilars business. Christine holds a BS in Biology from Wright State University and an MBA from the Fuqua School of Business at Duke University.